Nephros, Inc. (NEPH) Stock Rises 22.86% This Week; Should You Buy?

Nephros, Inc. (NEPH) stock is lower by -70.68% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives NEPH stock a score of 0 out of a possible 100. That rank is influenced by a short-term technical score of 0. NEPH's rank also includes a